The Rise of GLP-1 Weight Loss Injections In 2024, the percentage of overweight or obese adults prescribed GLP-1 medications increased almost sevenfold compared to 2019
Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression
The strongest evidence for the liver-fat effect comes from a phase 2a study in which retatrutide reduced hepatic lipid content by roughly 8182% at the 8 mg and 12 mg doses over 24 weeks , with the majority of participants reaching normal liver fat among the most pronounced pharmacological liver-fat reductions reported in a clinical trial
Semaglutide is an active ingredient currently available under three different brand names: Ozempic, Wegovy, and Rybelsus
Losing the weight was the next part of that, but I still gotta find a way to be a better husband and a better father tomorrow
The gut microbiome responds to total environmental input, not just one capsule per day